Kodikaz Therapeutic Solutions
UEI: NR6LLDATX535
• CAGE: 8CTC2
Overview
Awardee Type
Parent
Name
Kodikaz Therapeutic Solutions
Website
Headquarters
New York, NY
United States
United States
Most Recent Award
Aug. 15, 2021
Calculating
Federal grant recipient
KODIKAZ THERAPEUTIC SOLUTIONS INC
(UEI NR6LLDATX535, CAGE 8CTC2)
is headquartered in New York NY.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in May 2018 and
federally registered in
June 2019.
Federal Award Analysis
Kodikaz Therapeutic Solutions federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
KODIKAZ THERAPEUTIC SOLUTIONS INC
UEI
NR6LLDATX535
CAGE Code
8CTC2
SBA Certifications
None
Self Certifications
Hispanic American Owned
Self-Certified Small Disadvantaged Business
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 1, 2018
Initial Registration
June 17, 2019
Last Registration
March 12, 2024
Registration Activation
March 7, 2024
Registration Expiration
Feb. 14, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No